Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel three-step synthesis for ramelteon intermediate ensures high purity and scalable production for global pharmaceutical supply chains efficiently.
Patent CN108546720B reveals a green lipase-catalyzed route for Indobufen intermediates, offering high optical purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN113200993A details a novel metal-free synthesis of oxindole spirodihydrofurans using organocatalysis and iodine, offering cost-effective API intermediate manufacturing.
Patent CN121472200A reveals high-efficiency nitrilase mutant for chiral acid synthesis. Offers green manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN111943930A reveals a mild copper-catalyzed route for Lasmiditan. This process eliminates noble metals, offering significant cost reduction and scalable manufacturing for API intermediates.
Patent CN114805367A discloses novel triazolopyrimidine derivatives with potent USP28 inhibitory activity, offering a scalable route for high-purity pharmaceutical intermediate manufacturing.
Novel synthesis of Pramipexole related substance BI-II828BS ensures high purity for QC. Optimized route offers cost reduction and supply reliability for pharmaceutical manufacturers.
Novel LsCR mutant enables efficient synthesis of chiral alcohols for anticoagulants. Enhanced stability and activity reduce manufacturing costs for pharmaceutical intermediates.
Novel patent CN117050033B enables high-purity BI-II828BS production for quality control ensuring supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110225904A details a modular synthesis for cytotoxic benzodiazepine derivatives, offering improved purity and scalable manufacturing for antibody-drug conjugate intermediates.
Patent CN107922952B enables cost-effective NMN synthesis without PRPP. Discover scalable biocatalytic routes for high-purity pharmaceutical intermediates.
Novel preparation method for Bambuterol Impurity C ensures high purity reference standards and supply chain stability for pharmaceutical manufacturing.
Patent CN102010400A details a novel chiral resolution route for Rotigotine intermediates, offering high purity and streamlined manufacturing for reliable pharmaceutical supply chains.
Patent CN111057729B reveals enzymatic synthesis for high-purity Larotrectinib intermediates. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN104892540B reveals ionic liquid catalysis for naphthooxazinone derivatives offering green synthesis and supply chain advantages for reliable pharmaceutical intermediates supplier.
Patent CN117701523A reveals solvent-tolerant transaminase for high-purity sitagliptin intermediate manufacturing with significant supply chain cost reduction.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN101560171A reveals a novel synthesis for 5-DNSA. Achieve superior purity and yield for Labetalol production with our scalable pharmaceutical intermediates supply chain solutions.
Novel base-promoted synthesis offers significant cost reduction and scalability for high-purity xanthone manufacturing supply chains globally ensuring reliable procurement.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.